Search research articles
Contact Us
Filters
Showing results (61-70 of 145) with videos related to
Page
of 15
Sort By:
Haematologica
|
May 7, 2013
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials
Pier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, et al.
Blood Advances
|
March 18, 2020
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum
Andrés J M Ferreri, Marianna Sassone, Elisabetta Miserocchi, et al.
Blood
|
June 22, 2007
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini, Francesco Zaja, Caterina Patti, et al.
American Journal of Hematology
|
April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
James Bussel, Donald M Arnold, Elliot Grossbard, et al.
Blood
|
January 8, 2005
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma
Alessandro Rambaldi, Emanuela Carlotti, Elena Oldani, et al.
Oncotarget
|
June 4, 2015
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells
Michele Dal Bo, Tiziana D'Agaro, Stefania Gobessi, et al.
Hematological Oncology
|
April 2, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study
Francesca Maria Quaglia, Lara Mannelli, Luca Pagliaro, et al.
Leukemia & Lymphoma
|
October 10, 2009
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma
Enrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, et al.
Leukemia & Lymphoma
|
June 7, 2024
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care)
Ombretta Annibali, Alessia Castellino, Natalia Cenfra, et al.
Frontiers in Oncology
|
March 16, 2023
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax"
Sara Mohamed, Elisa Lucchini, Francesca Sirianni, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 145) with videos related to
Sort By:
Page
of 15
Haematologica
|
May 7, 2013
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials
Pier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, et al.
Blood Advances
|
March 18, 2020
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum
Andrés J M Ferreri, Marianna Sassone, Elisabetta Miserocchi, et al.
Blood
|
June 22, 2007
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini, Francesco Zaja, Caterina Patti, et al.
American Journal of Hematology
|
April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
James Bussel, Donald M Arnold, Elliot Grossbard, et al.
Blood
|
January 8, 2005
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma
Alessandro Rambaldi, Emanuela Carlotti, Elena Oldani, et al.
Oncotarget
|
June 4, 2015
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells
Michele Dal Bo, Tiziana D'Agaro, Stefania Gobessi, et al.
Hematological Oncology
|
April 2, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study
Francesca Maria Quaglia, Lara Mannelli, Luca Pagliaro, et al.
Leukemia & Lymphoma
|
October 10, 2009
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma
Enrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, et al.
Leukemia & Lymphoma
|
June 7, 2024
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care)
Ombretta Annibali, Alessia Castellino, Natalia Cenfra, et al.
Frontiers in Oncology
|
March 16, 2023
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax"
Sara Mohamed, Elisa Lucchini, Francesca Sirianni, et al.
Page
of 15